March 4th 2017
Raoul S. Concepcion, MD, calls for increased oncology education and information sharing among the urology community across the globe, as urologists play a critical role in delivering and managing cancer treatment.
January 5th 2017
As a result of the most recent presidential election, it is a big unknown what the new administration will bring as it relates to the future of healthcare in the US.
August 11th 2016
The lack of cooperation and inability to compromise, at the expense of our country’s best interests, has resulted in gridlock.
June 25th 2016
Over the past few months, an alarming number of events have surfaced that we, as providers of oncologic urology care, should take notice.
November 6th 2015
Raoul S. Concepcion, MD, FACS, director of Advanced Therapeutics at Urology Associates, PC, discusses healthcare's movement away from fee-for-service reimbursements.
June 17th 2015
The world of precision medicine is upon us and we as providers, especially those involved in the management of oncology patients, will need to be conversant and have an understanding of these various pathways and drivers in order to more effectively manage our patients
April 13th 2015
Management of elevated PSAs, or the next testing equivalent, and prostate cancer should default to the urology world, just like always.
December 15th 2014
In attending the Society of Urologic Oncology's annual meeting in Bethesda in early December, I was struck by the number of presentations focusing sharply on the burgeoning fields of biomolecular markers and immunotherapy and their application to urologic oncology.
October 23rd 2014
Over the past 6 months, we have had two studies that will profoundly affect our management of advanced prostate cancer patients.
September 8th 2014
The year was 1989, and I was one year away from finishing six years of residency in general surgery and urology.
July 24th 2014
I am sure that those of you who attended the AUA meeting in Orlando were struck by the number of presentations on the use of biomarkers and their role in better risk stratification and management of the urologic oncology patient.
March 20th 2014
When I first entered practice in 1990, I was fortunate to have senior partners and colleagues who offered sage advice, much of it based on retrospective analysis of their own successes and failures over time.
January 21st 2014
We enjoyed record attendance this year by both physicians and administrators, and despite the pressures of groups being purchased by integrated hospital systems, the organization continues to grow.
January 3rd 2014
Raoul Concepcion, MD, director of clinical research, urologic surgeon, Urology Associates, PC, in Nashville, Tennessee discusses some of the challenges that independent and community urologists face.
October 22nd 2013
We as physicians, especially surgeons, tend to operate on the same principle: When things go bad, especially when revenue goes down, we just work harder and see more patients, with the expectation that it will correct and we can maintain.
August 21st 2013
We should move away from directing therapy based on the primary site of malignancy and focus our efforts on inherent pathways common to the tumors, irrespective of the organ.
May 24th 2013
Raoul S. Concepcion, MD, from the Urology Associates, PC, Nashville, TN, discusses a recent FDA investigation into spikes in reported adverse events associated with the use of robotic-assisted surgery.
May 9th 2013
Raoul S. Concepcion, MD, from Urology Associates, PC, discusses the new guidelines on prostate cancer screening that were issued by the American Urological Association.